Image Credit: Canva (representational purpose only)
Mysterious Fog in the US , Canada and UK: A dense, eerie fog with a "burning chemical-like smell" has spooked a good part of North America and parts of the United Kingdom and Canada. With social media amplifying all concerns, this phenomenon has sparked attention across all social media platforms. However, at the heart of this mysterious fog are a conjunction of natural events, social psychology, and environmental conditions that culminated in all the conspiracy theories and public health fears. Here's a closer look at the mysterious fog, its potential causes, and the societal response it has triggered.
The first reports of this "mysterious fog" came in from Florida where a resident said that they experienced respiratory symptoms, feverish warmth, and stomach cramps after contact with the fog. Similar stories started flooding social media, and within a day or two, a sinister force seemed to sweep across the United States, Canada, and parts of the UK. From Texas to Minnesota, people reported weird odors and health issues that they thought were linked to this bizarre atmospheric event.
Some witnesses were said to see "white particles" swirling through the air; theories ranged from a chemical attack or experimental weapon to drone-related chemical dispersals and references to historical military experiments, such as the infamous 1950s "Operation Sea-Spray."
Fuel to the fire were added when videos and posts, hundreds of thousands in number, began circulating on social media sites like TikTok and X (formerly Twitter) speculating on the origin of the fog. Hashtags like #ToxicFog went trending for days. Hysteria created a self-reinforcing loop in which every post spurred further scrutiny and fear.
Fog is essentially a low-lying cloud formed when the air temperature cools to its dew point, causing water vapor to condense into tiny droplets or ice crystals. Several types of fog—advection fog, radiation fog, and valley fog—can form depending on conditions such as warm, moist air moving over cooler land or when temperatures plummet rapidly under clear skies.
Such chemical-like smell as reported during the occurrence of fog events is sometimes attributed to air pollution. It acts like a sponge, where it absorbs these pollutants, which include sulfur dioxide and nitrogen oxides, among others, that emit from industries. This mixture, therefore, leads to a stench that could be mistaken as unnatural or even toxic.
Also Read: Health Concerns Rise As US, Canada, and UK Come Under The Blanket Of Thick, Dense, Toxic Fog
High moisture levels from fog can significantly exacerbate symptoms related to respiration, but especially in already predisposed asthmatics and allergy patients. The connection of these symptoms with actual fever, stomach cramps, and puffy eyes is too remote. Experts assume that the irritating effects of entrapped pollutants trapped in fog tend to affect more the eyes and throat rather than the rest of the body affected by some report.
Social media amplified a natural weather event into a health epidemic. It made the personal experience of individuals become a cause for fear and speculation, a domino effect.
According to psychologists, this is a concept of selective perception, wherein once people's attention is drawn to environmental anomalies, they begin to notice them. This mirrors earlier panics, such as the Seattle windshield pitting panic of 1954. Then, atomic bomb testing caused fear in many and started to have people looking at their windshields for small marks that they had not seen before. Likewise, postings on the strangeness of the fog probably increased public awareness and suspicion, with people looking to attach unrelated symptoms to the phenomenon.
The fog hysteria shares a commonality with other instances of mass panic, such as the "drone sightings" of recent years or the Cold War-era fears of biological warfare.
Also Read: Mysterious Fog Is Making Americans Sick
These events underscore how fear can cloud judgment, especially when amplified by social media and sensationalist headlines. While historical cases, such as "Operation Sea-Spray," offer concrete evidence of the existence of unethical experiments, the jump from a natural weather condition to theories of chemical attacks exemplifies a more modern trend of connecting unrelated dots, all wonderfully seeded in distrust and anxiety.
Despite the swirling rumors, meteorologists and scientists are in agreement that the mysterious fog is not as alarming as it seems. It is well known that fog traps and amplifies pollutants, especially in urban and industrial regions. Moreover, winter months are the most conducive for fog formation, so its recent prevalence is unsurprising.
On the other hand, environmentalists advise that the fog should wake everyone up to increased levels of pollution. The reported odors and health irritations could be just symptoms of far deeper systemic issues like industrial emissions and lack of control over air quality.
The authorities must be transparent in their communication to combat misinformation and allay public fears. Governments and environmental agencies must provide timely updates on weather phenomena, air quality, and health risks. Initiatives like real-time pollutant tracking and public education campaigns can help demystify natural occurrences while addressing valid environmental concerns.
The mysterious Canada fog is a compelling case study in how environmental events intersect with psychology and societal dynamics. While rooted in natural phenomena, the fog became a vessel for collective fears, amplified by modern technology and historical anxieties.
In this information era where communication occurs at an almost lightning pace, the fog becomes a metaphor that reminds everyone about scientific literacy, environmental responsibility, and an effective balance when considering public concern. Whether perceived as a marvel of nature or as a tale that serves to teach, it left a very powerful mark in people's minds.
Credit: iStock
Weight-loss medications such as oral semaglutide have become increasingly popular for treating obesity. However, a new study suggests that a 45-minute, minimally invasive procedure called Endoscopic Sleeve Gastroplasty (ESG) may deliver greater short-term weight loss than oral semaglutide tablets.
Published in the Endoscopy journal, the study compared two established non-surgical obesity treatments—ESG and oral semaglutide 14 mg.
Researchers from AIG Hospitals, Hyderabad, found that patients who underwent ESG lost significantly more weight than those taking oral semaglutide after six months.
Patients treated with ESG achieved an average 12.72% total body weight loss, compared with 8.67% among those taking semaglutide. The difference remained significant even after adjusting for age, sex, BMI and diabetes.
"The most important message from this study is that obesity treatment has to be individualized. ESG appears to offer a stronger early push in weight loss, especially for patients who need a meaningful reduction in a short period," said Dr. Nitin Jagtap, Consultant Gastroenterologist at AIG Hospitals.
He added that ESG is not a shortcut but a structured intervention that helps patients reset eating habits and build sustainable lifestyle changes.
The retrospective study included 150 adults with obesity treated between January 2024 and April 2025. Of these, 50 underwent ESG, while 100 received oral semaglutide 14 mg once daily.
All participants also followed a calorie-deficient diet and moderate exercise plan, highlighting that both treatments work best alongside lifestyle modifications.
ESG also outperformed semaglutide in the number of patients achieving clinically meaningful weight loss.
No major adverse events were reported in either group.
Notably, by 12 months, the gap between the two treatments had narrowed. Average weight loss was 11.92% in the ESG group and 10.91% in the semaglutide group, with no statistically significant difference.
The findings are particularly relevant for India, where obesity often occurs alongside diabetes, fatty liver disease and cardiovascular risk at lower BMI levels than in Western populations, the researchers said.
The researchers noted that the findings should be interpreted carefully because this was a retrospective, single-centre study, not a randomized clinical trial.
They also stressed that the comparison was limited to oral semaglutide 14 mg and should not be extended to higher-dose injectable GLP-1 drugs or newer dual-incretin therapies, which may produce different results.
"Obesity care is entering a new phase where endoscopy, pharmacology, nutrition and lifestyle medicine must come together," said Dr. D. Nageshwar Reddy, Chairman of AIG Hospitals.
He emphasized that ESG and medications like semaglutide should be viewed as complementary options rather than competing therapies, with the shared goal of achieving and maintaining meaningful weight loss.
Endoscopic Sleeve Gastroplasty (ESG) is a minimally invasive procedure performed through the mouth without external incisions. Using an endoscope and suturing device, doctors reduce the stomach's size by placing internal stitches, helping patients feel full sooner without surgically removing part of the stomach.
Oral semaglutide belongs to the GLP-1 receptor agonist class of drugs. It reduces appetite, increases feelings of fullness and helps lower calorie intake. Unlike ESG, it requires daily medication, long-term adherence and continued affordability.
Credit: iStock
The US Food and Drug Administration (FDA) has expanded the approval of Vertex Pharmaceuticals' Casgevy (exagamglogene autotemcel), making it the first gene therapy approved for children as young as 2 years with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).
Earlier, the one-time CRISPR-based gene-editing therapy was approved only for patients aged 12 years and older. The expanded label is expected to make approximately 5,500 additional children in the US eligible for treatment, the company said.
The FDA said earlier intervention could help prevent irreversible organ damage and improve long-term health outcomes.
“With today’s decision, pediatric patients as young as 2 years of age can now access a critical additional treatment option to treat these debilitating, life-threatening diseases,” said Karim Mikhail, Acting Director of the FDA's Center for Biologics Evaluation and Research (CBER).
"Making this therapy available to younger patients opens a critical window for intervention and gives these children a meaningful chance at a healthier future," added Megha Kaushal, Acting Deputy Director of the FDA's Office of Therapeutic Products.
Also read: Scientific Breakthrough: US Scientists Create First Synthetic Cell That Eats and Reproduces
The expanded approval is backed by clinical trial data in children aged 5 to under 12 years.
For sickle cell disease:
For transfusion-dependent beta thalassemia:
Casgevy is a one-time gene-editing therapy that uses CRISPR technology to modify a patient's own blood stem cells, enabling the body to produce healthier red blood cells.
For people with sickle cell disease, it aims to prevent painful vaso-occlusive crises. In beta thalassemia, it can eliminate the need for regular blood transfusions in many patients.
“These disorders carry a heavy burden for children and their families, affecting growth, development, and long-term health in profound ways,” said Kaushal, also a pediatric hematologist. “Grounded in the scientific evidence that earlier treatment reduces the risk of lasting end-organ damage, making this therapy available to younger patients opens a critical window for intervention and gives these children a meaningful chance at a healthier future.”
The FDA granted the expanded approval through its Commissioner's National Priority Voucher program, completing the review in 53 days.
Vertex said it has also submitted applications to expand Casgevy's use in the United Kingdom and Saudi Arabia, where regulatory reviews are currently underway.
Credit: AI-generated image
A popular snack brand is currently under scrutiny after its multiple products were classified under the US Food and Drug Administration's (FDA) Class I recall. The move came after concerns over its product being contaminated with Salmonella surfaced.
According to the FDA, the recall was initiated in May by Utz Quality Foods LLC after the company found out that a seasoning ingredient containing milk powder, sourced from California Dairies Inc. through a third-party supplier, may have been contaminated with Salmonella.
The recall affects a few varieties of its Zapp's and Dirty’s potato chips, including Zapp's Bayou Blackened Ranch, Big Cheezy, and Salt and Vinegar potato chips, as well as Dirty brand Salt and Vinegar, Maui Onion, and Sour Cream and Onion potato chips.
According to the FDA, Utz said the seasoning batches tested negative before being used in production, but the decision to recall the products was taken as a precautionary measure.
While no illnesses have been reported yet, the FDA's move indicates there is a reasonable probability that consuming these products could result in adverse health consequences and even death.
Also read: Cyclospora Parasite Spreads Across 17 US States: How To Prevent Parasitic Infection
The FDA uses three categories to classify product recalls based on the level of public health risk. A Class I recall is usually reserved for products that pose the highest risk to consumers.
It is issued when there is a reasonable probability that consumption or use of the product will cause serious health problems or death.
Salmonella infection, known as salmonellosis, usually develops between six hours and six days after consuming contaminated food.
Also read: Doctors Find 38 Parasites In UK Woman’s Brain After Her Trip To India; What Is Neurocysticercosis?
Common symptoms of salmonellosis include:
Most healthy people recover within four to seven days without targeted treatment. However, it can become severe when the infection enters the bloodstream. Deemed as a medical emergency, this situation prompts urgent attention.
Those with weakened immunity systems, such as young children, older adults, and women who are expecting are at the greatest risk of developing serious complications from salmonellosis. In rare cases, the infection can become life-threatening.
The FDA has advised consumers not to eat the recalled potato chips. It has also said that anyone who has purchased the affected products should either discard them or return them to the place where they bought them for a refund.
The regulatory body has also said that consumers who experience symptoms of salmonellosis after eating the recalled products, especially those at higher risk for complications, should seek medical care immediately.
Although no infection cases linked to the recalled chips have been reported to date, health officials say the recall is intended to prevent potential cases before they occur.
© 2024 Bennett, Coleman & Company Limited